Elizabeth Nielson, PhD
Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment PTSD, and psilocybin-assisted treatment of treatment resistant depression. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her program of research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.Upcoming Programs by Elizabeth Nielson, PhD
Psychedelic Integration: Experiential Practice Retreat for Clinicians
Oct 19 - Oct 24, 2021
This 5-day experiential retreat is designed for therapists who practice psychedelic integration or psychedelic-assisted therapy, or are training to do so. Experiential training is a component of training in which therapists experience the transformative process of the given modality themselves, and apply their insights to their own lives and to their professional work with others. […]
MENLA
